Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma

DESIGN AND INTERVENTION This was a retrospective analysis of 8,298 patients aged 16–75 years treated within the German Hodgkin Study Group trials HD4 to HD12. Among this study population, 394 patients had LPHL and 7,904 patients had cHL. Eligibility criteria included biopsy-proven Hodgkin’s lymphoma histology at diagnosis and adequate organ function… CONTINUE READING